Last reviewed · How we verify
NCT05109260: Destiny
Destiny: D-dimer. Investigating D-dimer Levels Using Point-of-Care (POC) Testing at Primary Care.
trial testing Point-of-Care Immunoassay device in Deep Vein Thrombosis in 244 participants. Status unknown.
1 September 2022
Quick facts
| Lead sponsor | University of South Wales |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 244 |
| Start date | 26 October 2021 |
| Primary completion | 1 September 2022 |
| Estimated completion | 1 March 2023 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Point-of-Care Immunoassay device
Conditions studied
- Deep Vein Thrombosis — all drugs for Deep Vein Thrombosis →
Sponsor
University of South Wales
Who can join
18 and older, any sex, with Deep Vein Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
DESTINY D-Dimer is an observational feasibility study, and a collaboration between the University of South Wales and Cwm Taf Morgannwg University Health Board (CTMUHB). The study is based at St. John's Medical Practice in Aberdare, where participant recruitment will take place. Blood D-dimer data will be collected from CTMUHB Pathology Laboratory services, at Prince Charles Hospital. Study blood samples will be obtained by the research student, LAH, under the direction of Dr Owen Thomas at St John's Medical Centre. The participant data will be collected by the research student who will conduct a Wells' Risk Score and perform D-dimer POC tests to generate quantitative data. Data will later be compared by the research student with the diagnoses obtained from Secondary Care at Prince Charles Hospital via analysis of medical records to include a laboratory generated D-Dimer results and additional diagnostics (eg. Doppler). A laboratory based analytical verification of D-dimer POC tests will be undertaken to compare with the current laboratory method. The study will compare the data from the D-dimer POC tests and those gained using laboratory methods at Prince Charles Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05109260
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deep Vein Thrombosis
Currently open trials in the same condition.
- NCT06886516 — Apixaban in Thrombocytopenia · EARLY_PHASE1 · recruiting
- NCT06842446 — Systematic Machine Learning Algorithm for Rapid Thrombosis Detection · NA · recruiting
- NCT06581965 — inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Tota · Phase 4 · recruiting
- NCT06989255 — A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Data Set for Research Purposes. · recruiting
- NCT06727669 — Longitudinal Cohort of Thrombosis and Hemostasis Diseases · recruiting
Other University of South Wales trials
Trials by the same sponsor.
- NCT06981130 — ASPIRE II. Supporting Antibiotic Stewardship in Primary Care Via POCT · NA · completed
- NCT06912022 — ASPIRE I: Supporting Antibiotic Stewardship in Primary Care Via POCT · completed
- NCT05603234 — Symptom Monitoring and Menopausal Symptoms · NA · completed
- NCT04099095 — A Mental Health Social Prescribing Trial (British Red Cross) · NA · withdrawn
- NCT04118673 — Secondary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health (S-PLAC 2) · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05109260 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Wales
- Last refreshed: 5 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05109260.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing